OSTX (OS Therapies Inc.) שיעור רווח גולמי

The gross margin of OS Therapies Incorporated (OSTX) on the GURU.Markets terminal displays a chart of the metric, where the value 0.00 serves as the baseline indicator. The trend confirms the protection of medical developments in the US, although it is impacted by challenges with overseas drug registration and raw material import risks. Additionally, strict transportation requirements for biologics to maintain their activity are weighing on the price action.
פילוחים אנליטיים ודוחות נתונים של חברת OS Therapies Inc (OSTX)

For OS Therapies Incorporated (OSTX), the monetization potential of osteosarcoma immunotherapy and the orphan drug status of OST-HER2 determine the future cost structure and pricing policy. By analyzing the annual gross margin, an investor assesses production efficiency through the share of revenue minus the cost of goods sold, where steady growth of this indicator confirms the business's ability to generate excess capital and maintain a monopoly advantage in the market.